Don E. Smith

5.6k citations

120 papers · 4.5k · 1 hit paper · h-index 36

Impact in

Virology top 0.5%
- HIV Research and Treatment
Infectious Diseases top 1%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in

Virology 35
- HIV Research and Treatment 35
Infectious Diseases 56
- HIV/AIDS Research and Interventions 37
- HIV/AIDS drug development and treatment 27

Co-authors: David A. Cooper (20 shared papers)John J. Zaunders (14 shared papers)Anthony D. Kelleher (12 shared papers)Brian Gazzard (13 shared papers)Gilbert R. Kaufmann (8 shared papers)Pat Grey (7 shared papers)Andrew D Carr (10 shared papers)Mark Theo Bloch (8 shared papers)
Journals: AIDS (17 papers)Sexual Health (8 papers)HIV Medicine (6 papers)The Journal of Infectious Diseases (5 papers)International Journal of STD & AIDS (5 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Don E. Smith

116 papers receiving 4.3k citations

Don E. Smith's Hit Papers

align trajectories log scale

Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study 2018 · 295 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2018 The Lancet HIV

Peers

Countries citing papers authored by Don E. Smith

Since Specialization

Citations

This map shows the geographic impact of Don E. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don E. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don E. Smith more than expected).

Fields of papers citing papers by Don E. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don E. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don E. Smith. The network helps show where Don E. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Don E. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don E. Smith Line = papers co-authored together Don E. Smith links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Characterization of CD4+ CTLs Ex Vivo The Journal of Immunology ·Victor Appay, John J. Zaunders, Laura Papagno, Julian K. Sutton, Anele Waters, Philippa Easterbrook, Pat Grey, Don E. Smith	2002	472
2	Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study The Lancet HIV ·Andrew Edwin Grulich, Rebecca Guy, Janaki Amin, Fengyi Jin, Christine Selvey, Heather-Marie Ann Schmidt, Iryna Zablotska, Karen L. Price Hit paper breakdown →	2018	295
3	Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir AIDS ·Allison Martin, Don E. Smith, Andrew D Carr, Clare L. Ringland, Janaki Amin, Sean Emery, Jennifer Hoy, Cassy Workman	2004	255
4	Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells Nature Medicine ·Ronald T. Mitsuyasu, Thomas C. Merigan, Andrew D Carr, Jerome A. Zack, Mark A. Winters, Cassy Workman, Mark Theo Bloch, Jacob Paul Lalezari	2009	212
5	HIV lipodystrophy: prevalence, severity and correlates of risk in Australia HIV Medicine ·J. Philip Miller, Andrew D Carr, Sean Emery, Matthew G. Law, Simon Alexander Mallal, David A Baker, Don E. Smith, John Martin Kaldor	2003	168
6	The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy AIDS ·Gilbert R. Kaufmann, Mark Theo Bloch, Robert James Finlayson, John J. Zaunders, Don E. Smith, David A. Cooper	2002	146
7	Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors The Lancet ·Han Hee Lee, Priscilla A. Swanson, Joseph D. Rosenblatt, I-Ling Chen, W Cullen Sherwood, Don E. Smith, Gary E. Tegtmeier, Lawrence P. Fernando	1991	110
8	Increased Plasma Interleukin‐7 Level Correlates with Decreased CD127 and Increased CD132 Extracellular Expression on T Cell Subsets in Patients with HIV‐1 Infection The Journal of Infectious Diseases ·Sarah Christina Sasson, John J. Zaunders, Giulia Zanetti, Eleanor M. King, Kate Merlin, Don E. Smith, Keith K. Stanley, David A. Cooper	2006	100
9	Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy AIDS ·Gilbert R. Kaufmann, Mark Bloch, John J. Zaunders, Don E. Smith, David A. Cooper	2000	90
10	Impact of Therapeutic Immunization on HIV‐1 Viremia after Discontinuation of Antiretroviral Therapy Initiated during Acute Infection The Journal of Infectious Diseases ·Sabine Kinloch‐de Loes, Bruno Hoen, Don E. Smith, Brigitte Autran, Fiona C. Lampe, Andrew N. Phillips, Li‐Ean Goh, Jan Andersson	2005	88
11	Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection AIDS ·Gilbert R. Kaufmann, John J. Zaunders, Philip Cunningham, Anthony D. Kelleher, Pat Grey, Don E. Smith, Andrew Jonathan Carr, David A. Cooper	2000	86
12	Efavirenz and chronic neuropsychiatric symptoms: a cross‐sectional case control study HIV Medicine ·Tonia Anahi Rihs, Kim Begley, Don E. Smith, J Sarangapany, Alison Callaghan, Monica R. Kelly, Jeffrey John Post, Jeffrey I. Gold	2006	85
13	Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence? AIDS ·Don E. Smith, Bruce D. Walker, David A. Cooper, Eric S. Rosenberg, John Martin Kaldor	2004	83
14	HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults Nature Medicine ·Nila J. Dharan, Paul Sung-Hao Yeh, Mark Bloch, Miriam M. Yeung, David A Baker, Jerick Guinto, Norman Roth, Sarah Ftouni	2021	81
15	Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study The Lancet HIV ·Andrew Edwin Grulich, Fengyi Jin, Benjamin Robert Bavinton, Barbara Yeung, Mohamed Hammoud, Janaki Amin, Gesalit Cabrera, Shawn Clackett	2021	79
16	Dietary calorie restriction in the Emory mouse: effects on lifespan, eye lens cataract prevalence and progression, levels of ascorbate, glutathione, glucose, and glycohemoglobin, tail collagen breaktime, DNA and RNA oxidation, skin integrity, fecundity, and cancer Mechanisms of Ageing and Development ·Allen Taylor, Ruth D. Lipman, Jessica Jahngen-Hodge, Victoria Jane Palmer, Don E. Smith, Nita Padhye, Gerard E. Dallal, Deana E. Cyr	1995	77
17	Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection Blood ·John J. Zaunders, Cynthia Mee Ling Munier, Daniel E. Kaufmann, Susanna Ip, Pat Grey, Don E. Smith, Tim Ramacciotti, Dick Quan	2005	74
18	Cognitive Impairment in Folate-Deficient Rats Corresponds to Depleted Brain Phosphatidylcholine and Is Prevented by Dietary Methionine without Lowering Plasma Homocysteine Journal of Nutrition ·Aron M. Troen, Wei–Hsun Chao, Natalia A. Crivello, Kristen E. D’Anci, Barbara Shukitt‐Hale, Don E. Smith, Jacob Selhub, Irwin H. Rosenberg	2008	72
19	Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy AIDS ·Krista J. Siefried, Limin Mao, Lucette A. Cysique, John Rule, Michelle Giles, Don E. Smith, James H. McMahon, Tim R. H. Read	2017	64
20	Barriers to HIV testing and characteristics associated with never testing among gay and bisexual men attending sexual health clinics in Sydney Journal of the International AIDS Society ·Damian P. Conway, Martin Holt, Deborah L. Couldwell, Don E. Smith, Stephen C. Davies, Anna M. McNulty, Phillip Keen, Philip Cunningham	2015	61

About Don E. Smith

Don E. Smith is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 120 papers that have together received 4.5k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (37 papers), HIV Research and Treatment (35 papers), HIV/AIDS drug development and treatment (27 papers), HIV-related health complications and treatments (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (14 papers), HIV, Drug Use, Sexual Risk (6 papers), HIV/AIDS oral health manifestations (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Virology (1.4k citations), Infectious Diseases (1.7k citations), Emergency Medicine (672 citations), Immunology (828 citations) and Aging (56 citations). Don E. Smith has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include David A. Cooper, John J. Zaunders, Anthony D. Kelleher, Brian Gazzard, Gilbert R. Kaufmann, Pat Grey, Andrew D Carr, Mark Theo Bloch, Sean Emery and Matthew G. Law. Their work appears in journals such as AIDS, Sexual Health, HIV Medicine, The Journal of Infectious Diseases and International Journal of STD & AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Don E. Smith

Impact in

Papers in i

In The Last Decade

Don E. Smith

Don E. Smith's Hit Papers

Peers

Countries citing papers authored by Don E. Smith

Fields of papers citing papers by Don E. Smith

All Works

About Don E. Smith

Explore authors with similar magnitude of impact

Papers in